Does hepatitis B treatment reduce the incidence of hepatocellular carcinoma?


  • Morris Sherman M.B., B.Ch., Ph.D., F.R.C.P.(C)

    Corresponding author
    1. Department of Medicine Division of Gastroenterology University of Toronto Toronto, ON, Canada
    • Toronto General Hospital, 585 University Ave., Toronto, ON, M5G 2N2, Canada===

    Search for more papers by this author
    • fax: 416-591-2107

  • See Article on Page 98

  • Potential conflict of interest: Dr. Sherman consults and is on the speakers' bureau for Bristol-Myers Squibb and Gilead.

No abstract is available for this article.